SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,613,738 | +0.9% | 1,654,470 | +10.0% | 0.34% | +48.2% |
| Q2 2023 | $45,224,368 | -10.0% | 1,504,470 | +8.4% | 0.23% | -30.1% |
| Q1 2023 | $50,266,045 | +38.3% | 1,387,415 | +36.1% | 0.33% | +12.4% |
| Q4 2022 | $36,352,010 | +35.2% | 1,019,120 | +28.3% | 0.29% | +69.6% |
| Q3 2022 | $26,881,000 | +17.0% | 794,120 | 0.0% | 0.17% | +26.7% |
| Q2 2022 | $22,966,000 | -19.1% | 794,120 | -9.5% | 0.14% | +5.5% |
| Q1 2022 | $28,375,000 | +55.0% | 877,945 | +39.8% | 0.13% | +85.5% |
| Q4 2021 | $18,311,000 | – | 627,945 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |